Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Acoustic Neuroma Treatment & Management

  • Author: Joe Walter Kutz, Jr, MD, FACS; Chief Editor: Arlen D Meyers, MD, MBA  more...
 
Updated: May 13, 2016
 

Medical Therapy

Acoustic neuromas are managed in one of the following 3 ways: (1) surgical excision of the tumor, (2) arresting tumor growth using stereotactic radiation therapy, or (3) careful serial observation.

Observation

Simple observation without any therapeutic intervention has been used in the following groups of patients:

  • Elderly patients
  • Patients with small tumors, especially if their hearing is good
  • Patients with medical conditions that significantly increase the risk of operation
  • Patients who refuse treatment
  • Patients with a tumor on the side of an only hearing ear or only seeing eye
    • In a number of series reported to date, the individuals who are being observed ultimately require therapeutic intervention in between 15-40%.
    • During an observation period, most (70% or more) patients who are eligible for hearing conservation surgery initially lost their eligibility.
    • Telian has analyzed the important variables that should be evaluated when observation is considered, and these include the following:[3] 1) preoperative hearing in both ears, 2) the risk of immediate hearing loss as a consequence of surgery, 3) the risk of facial nerve paralysis, 4) the risk of other surgical complications and their seriousness, 5) the patient's life expectancy, 6) the size of the tumor, 7) tumor growth rate, and 8) patients with neurofibromatosis type 2 (NF2) or bilateral tumors.

Stereotactic radiotherapy

Stereotactic radiotherapy has emerged within the last 20 years as an alternative to microsurgery for selected patients with acoustic neuroma. Stereotactic radiation therapy makes use of one of several radiation sources and is administered using a variety of different machines with proprietary names (eg, Gamma Knife, CyberKnife, BrainLAB).

Stereotactic therapy uses radiation delivered to a precise point or series of points to maximize the amount of radiation delivered to target tissues while minimizing the exposure of adjacent normal tissues. It can be delivered as a single dose or as multiple fractionated doses.

The effects of radiation delivered at the current low dose likely prevents further tumor growth by causing obliterative endarteritis of the vessels supplying the tumor. Radiosurgery may affect tumor cells undergoing mitosis by causing double strand DNA breaks. Hansen et al demonstrated acoustic neuroma cells are radioresistant at the current low-dose radiation used with radiosurgery.[4]

A study by Boari et al study of patients with vestibular schwannomas (mean tumor volume 1.94 cm) found Gamma Knife radiotherapy for vestibular schwannomas to be safe and effective, providing tumor control in 97.1% of the study’s patients and tumor volume reduction in 82.7% of them; the mean relative volume reduction in the latter group was 34.1%.[5]

Comparison of microsurgery and stereotactic radiation is difficult for the following reasons:

  • Tumor size is inconsistently reported in the literature
  • Data using the lower radiation dosages are available for only the past 10 years
  • Because the goal of radiotherapy is control of tumor growth, understanding whether posttreatment neuroimaging reflects adequate treatment or merely the natural history of vestibular schwannomas is difficult
  • No data concerning the risk for secondary tumor induction by radiotherapy are available

Advantages of radiation therapy include the following:

  • Decreased length of stay
  • Decreased cost
  • Rapid return to full employment
  • Lower immediate posttreatment morbidity and mortality

Disadvantages of stereotactic radiation include the following:

  • Necessity for regular monitoring and frequent rescanning (in the end, costs associated with long-term monitoring could exceed those of surgery)
  • Does not eliminate the tumor and may fail to control tumor growth, sometimes requiring salvage surgery
  • Higher incidence of trigeminal nerve injury
  • Unknown long-term incidence of secondary malignancies. The best current estimates of developing a secondary malignancy from the radiosurgery are 1 in a 1000 patients over 30 years
  • Does not address disequilibrium and may lead to long-term balance dysfunction

Fractionated stereotactic radiotherapy provides very good tumor control of acoustic neuroma, but it also carries a risk of the patient developing hydrocephalus. It is necessary before treatment to closely monitor patients at high risk (ie, those with larger tumors with partial effacement of the fourth ventricle) and to monitor them more closely during follow-up. Before tumor diameter grows to larger than 2 cm, it would be beneficial to offer treatment to patients with progressive acoustic neuroma while the risk of hydrocephalus is low.[6]

Stereotactic radiosurgery and fractionated stereotactic radiotherapy have the potential for hearing preservation, at least in the short-term. Hearing preservation is dependent on multiple factors including tumor size, tumor location, and radiation dose. Most centers use a dose of 12-13 Gy at the 50% isodose line when considering hearing preservation. Hearing preservation is also dependent on the radiation dose to the cochlea, cochlear nerve, and cochlear nucleus. Kim et al recently noted transient volume expansion that is commonly seen after radiosurgery portends the worse prognosis for hearing preservation.[7]

Next

Surgical Therapy

Surgical removal remains the treatment of choice for tumor eradication. Various surgical approaches can be used to remove acoustic tumors. Each approach is discussed in detail in the following sections.

Previous
Next

Preoperative Details

Three different approaches are used in the management of acoustic neuromas, the retrosigmoid, translabyrinthine, and middle fossa approaches. All have advantages and disadvantages as indicated below.

Advantages of the retrosigmoid approach

See the list below:

  • The retrosigmoid approach can be applied to all acoustic tumors and to many other histologic tumor types. It can be used for operations that sacrifice hearing and operations that attempt to conserve hearing. Its only limitation in this respect is its inapplicability for small tumors that occupy the far-lateral portions of the internal auditory canal.
  • The retrosigmoid approach provides the best wide-field visualization of the posterior fossa. The inferior portions of the cerebellopontine angle and the posterior surface of the temporal bone anterior to the porus acusticus are much more clearly observed than via the translabyrinthine approach. Panoramic visualization is especially helpful when displacement of nerves is not predictable, which occurs commonly with meningiomas.
  • Hearing conservation surgery can be attempted even for relatively large tumors via the retrosigmoid approach. Destruction of the labyrinth is not required as part of the retrosigmoid approach.

Disadvantages of the retrosigmoid approach

See the list below:

  • The retrosigmoid approach may require cerebellar retraction or resection. Manipulation of the cerebellum provides opportunities for postoperative edema, hematoma, infarction, and bleeding.
  • Increased incidence of cerebrospinal fluid leak occurred in some series.
  • The retrosigmoid approach is associated with greater likelihood of severe protracted postoperative headache.
  • The highest incidence of tumor recurrence or persistence occurs with retrosigmoid approaches.

Advantages of the translabyrinthine approach

See the list below:

  • The translabyrinthine approach provides the best view of the lateral brain stem facing the acoustic tumor.
  • Retraction of the cerebellum is almost never necessary.
  • The fundus and lateral end of the internal auditory canal are completely exposed; the facial nerve can be identified at a location where it is undistorted by tumor growth and compressed into the labyrinthine segment, decreasing the risk of delayed postoperative facial nerve palsy.
  • Incidence of cerebrospinal fluid leak is decreased in some series.
  • If the facial nerve has been divided or sacrificed, the translabyrinthine approach may allow restoration of the facial nerve continuity by rerouting the facial nerve and performing a primary anastomosis. Consequently, interposition graft can sometimes be avoided.
  • Facial function is more frequently preserved in some series.

Disadvantages of the translabyrinthine approach

See the list below:

  • Hearing sacrifice is complete and unavoidable.
  • The inferior portions of the cerebellopontine angle and cranial nerves are not as well visualized as they are in the retrosigmoid approach. The temporal bone anterior to the porus acusticus is also less well visualized.
  • A fat graft is required. Removal of fat from the abdomen creates opportunities for donor site complications, including hematoma, bleeding, and infection.
  • The sigmoid sinus is more vulnerable to injury. Bleeding from the sigmoid sinus can be difficult to control and can significantly increase operative blood loss. If a dominant sigmoid sinus is occluded during the operation, postoperative intracranial pressure elevation or venous infarct can occur.
  • A high jugular bulb or anteriorly placed sigmoid sinus can substantially compromise the space available for tumor removal. Occasionally, the space is so contracted that another approach has to be selected.

Advantages of the middle cranial fossa approach

See the list below:

  • It is the only procedure that fully exposes the lateral third of the internal auditory canal without sacrificing hearing.
  • It is extradural.

Disadvantages of the middle cranial fossa approach

See the list below:

  • The facial nerve generally courses across the anterior superior portion of the tumor. Consequently, it is in the way during tumor removal and is more vulnerable to injury. Although long-term facial nerve outcomes are as good with the middle cranial fossa approach as with other approaches, temporary postoperative paresis is more common.
  • The risk of dural laceration and avulsion becomes increasingly more likely as patients become older. The dura mater in elderly patients is more friable. This becomes especially noticeable during the sixth and seventh decades of life.
  • The approach provides only very limited exposure of the posterior fossa.
  • The operation is technically difficult and demanding.
  • Some patients incur postoperative trismus related to manipulation and/or injury to the temporalis muscle.
  • The temporal lobe must be retracted, presenting the opportunity for temporal lobe injury, usually in the form of a hematoma that is asymptomatic and, therefore, probably occurs more frequently than is realized. Scattered reports exist of seizure disorder following middle cranial fossa surgery, presumably due to temporal lobe injury.

Approach Selection

A variety of different considerations go into deciding which approach should be used for any individual patient. These variables are detailed below.

Preoperative hearing level

If the patient has no useful hearing, either the translabyrinthine or the retrosigmoid approach is selected, depending upon the experience and training of the surgeon. In most centers performing large numbers of surgeries for acoustic tumors, the translabyrinthine approach is preferred. Opinions vary considerably about what constitutes useful hearing. The 50/50 rule is frequently quoted. The rule suggests that individuals with a pure-tone average greater than 50 dB and speech discrimination less than 50% do not have useful or salvageable hearing. Other surgeons have stricter criteria and consider only individuals with better than a 30-dB pure-tone average and more than 70% discrimination for hearing conservation operations.

Auditory brainstem response

Normal preoperative ABR findings favor hearing conservation. Marked abnormalities of ABR wave morphology or increased wave I-III and I-V latencies make hearing conservation less feasible.

Electronystagmography

An abnormal caloric test on electronystagmography (ENG) increases the likelihood of successful hearing conservation surgery. The ENG tests the horizontal semicircular canal, which is innervated by the superior vestibular nerve. A normal ENG finding arguably demonstrates that the superior vestibular nerve is normal. Consequently, the acoustic tumor must have originated from the inferior vestibular nerve, which is directly adjacent to the cochlear nerve. Surgical removal, then, is more likely to directly injure the cochlear nerve or interfere with cochlear blood supply. Vestibular evoked myogenic potential (VEMP) testing is abnormal when the inferior vestibular nerve is affected. As a result, an abnormal VEMP with normal caloric testing on ENG strongly suggests an inferior vestibular nerve tumor with poorer hearing preservation.

Tumor size

Opportunities for hearing conservation decrease as tumors become larger. Hearing is much more difficult to conserve when tumors are 1.5-2.0 cm in diameter than if they are small intracanalicular tumors. Consequently, some surgeons limit hearing conservation surgery to smaller tumors, preferring to use a translabyrinthine approach to maximize the chance of facial nerve conservation for larger tumors.

Tumor position

If hearing conservation is to be attempted and the tumor lies within the lateral portions of the internal auditory canal, many surgeons prefer a middle fossa approach. The middle fossa approach permits direct exposure of the lateral end of the internal auditory canal without sacrificing hearing. The approach is frequently used for any tumor lying completely within the internal auditory canal, although tumors limited to the medial portions of the internal auditory canal can be managed using a retrosigmoid approach. Some surgeons extend the use of the middle fossa technique to include tumors that extend as much as 0.5-1.0 cm into the cerebellopontine angle. Division of the superior petrosal sinus may be required to gain sufficient access to the posterior fossa with larger tumors.

Generally, however, tumors that have significant volume medial to the plane of the porus acousticus are extirpated using a retrosigmoid approach if hearing is to be conserved. If hearing conservation is not an issue, the retrosigmoid approach is sometimes preferred for tumors with significant inferior extension since the lower cranial nerves are better visualized with a retrosigmoid approach. Occasionally, the retrosigmoid approach is combined with a translabyrinthine approach for such large acoustic neuromas.

Relevant anatomy

The following anatomic variations can make the translabyrinthine approach much more difficult and at times impossible.

  • High-riding jugular bulb: In some individuals, the jugular bulb may actually ride up above the level of the inferior internal auditory canal.
  • Anteriorly placed sigmoid sinus: In such circumstances, the distance between the sigmoid sinus and the external auditory canal may be a few millimeters or less. Such a dramatic limitation of the space within which the surgeon has to operate not only makes a successful tumor extirpation much more difficult but puts the facial nerve and the displaced sinus itself at significantly increased risk of injury.
  • Contracted sclerotic mastoid: Such mastoid cavities provide little room for tumor removal. Moreover, they are often associated with suppurative otitis media, in itself a contraindication to the translabyrinthine approach.
  • Reduced or absent flow in the contralateral sinus: Previous operation, trauma, congenital anomalus development, and previous or concurrent disease can all result in markedly reduced or absent venous outflow through the contralateral sinus. In such cases, consideration may be given to a retrosigmoid approach merely because it reduces the risk of injury to the remaining sinus, occlusion of which would result in catastrophic venous infarction.

Surgeon preference

Some surgeons have more experience and are much more comfortable with one approach relative to another. Generally, such preferences should be followed. However, if hearing conservation is a realistic option using an approach unfamiliar to the primary surgeon, consideration should be given to referring the patient to someone who is familiar with the appropriate approach.

Patient preference

Patient preferences should be carefully considered even when they do not conform to the surgeon's judgment. Some patients are adamant about going to any lengths for hearing conservation even when the treating physician is quite convinced that the patient's hearing is so poor as to be of little or no practical utility. Some patients willingly sacrifice even good hearing if doing so even slightly enhances the possibility of successful facial nerve preservation. Some patients have very clear-cut opinions about one type of incision versus another (sometimes based on cosmetic consideration).

Previous
Next

Intraoperative Details

Translabyrinthine approach

The translabyrinthine approach is the most versatile of the 3 common approaches to the cerebellopontine angle. The main disadvantage is profound deafness in the operated ear due to violation of the membranous labyrinth. In general, even the largest acoustic neuromas can be removed through a translabyrinthine craniotomy. In addition, the facial nerve is found at the fundus of the internal auditory canal where the vertical crest (Bill’s bar) provides a natural plane for facial nerve dissection from the superior vestibular nerve. At the author’s institution, the translabyrinthine approach is preferred with any acoustic neuroma over 2 cm or in an ear with poor hearing.

The patient is laid supine and a Mayfield head frame may be used. An incision is then made two finger-breadths from the postauricular sulcus. The temporalis muscle and mastoid periosteum are identified. The skin flap is then elevated anteriorly, leaving as much periosteum down as possible. The periosteum is then incised along the linea temporalis and then towards the mastoid tip in a T-shaped fashion. This will allow a water-tight second layer for closure to prevent postoperative cerebrospinal fluid leakage. The mastoid periosteum is then elevated from the underlying mastoid bone. Often, the emissary vein is encountered and this can be controlled with bipolar coagulation and/or bone wax.

A wide cortical mastoidectomy is performed. The middle and posterior fossa dura are identified as well as the sigmoid sinus. The bone is removed from these structures to allow retraction of the temporal lobe dura and sigmoid sinus. Next, the antrum, lateral semicircular canal, and vertical facial nerve are identified.

The incus is removed and a facial recess is performed. The in tensor tympani tendon is sectioned and the eustachian tube is packed with oxidized cellulose packing. The middle ear space is then packed with temporalis muscle.

A labyrinthectomy is performed and the jugular bulb is identified. The internal auditory canal is subsequently identified and troughs are developed both superiorly and inferiorly around the internal auditory canal until approximately 270° of internal auditory canal is exposed. The remaining bone is then removed from the internal auditory canal and the facial nerve is found as it turns into the labyrinthine segment. The superior vestibular nerve is then followed out to the ampullated end of the superior semicircular canal.

At this point, the transverse crest and vertical crest (Bill’s bar) are identified. The superior vestibular nerve is then reflected inferiorly from the ampullated end of the superior semicircular canal. The facial nerve can often be found superior medial to this and is confirmed using a facial nerve stimulator. At this point, the tumor is generally debulked and the facial nerve is located at the origin from the brain stem. Once the tumor is adequately debulked, the acoustic neuroma is then dissected from the facial nerve. Often, the facial nerve is very adherent to the acoustic neuroma around the porus of the internal auditory canal.

Once the tumor has been removed, the posterior fossa dura is then re-approximated. Fat is harvested from the abdomen and packed into the surgical defect. The periosteal and skin layers are closed in a water-tight fashion. The patient wears a pressure dressing for 3 days.

Retrosigmoid approach

The patient may be placed in the supine position on the operating table and with the head toward the contralateral shoulder. The true lateral or park-bench position is still used by some surgeons because it permits the occiput to be rotated a little bit more superiorly. This allows a slightly more direct view of the internal auditory canal.

The operation is performed through either a vertically oriented linear incision or an anteriorly based U-shaped flap. An occipital craniotomy is then performed. Any mastoid air cells are carefully waxed off to prevent postoperative cerebrospinal fluid leak. The dura is opened and the arachnoid incised. The cerebellum frequently falls away from the posterior surface of the temporal bone after the cisterna magna has been opened. Hyperventilation, steroids, and intraoperative diuretics (principally mannitol) are used to reduce intracranial pressure and to provide additional exposure with a limited amount of retraction. Nonetheless, gentle cerebellar retraction is occasionally required especially in larger tumors.

Once adequate exposure has been obtained, the tumor is clearly visualized along with the brain stem and lower cranial nerves. However, cranial nerves VII and VIII are rarely observed because they are almost always pushed forward and lie across the anterior surface of the tumor, which cannot be visualized. Debulking of the tumor is the next step and must be carefully performed so as to maintain the anterior portions of the capsule in order to prevent injury to cranial nerve VII and/or VIII. Once the tumor has been substantially debulked, the posterior wall of the internal auditory canal can be removed using a high-speed drill.

Great care must be taken to avoid injuring the labyrinth while removing the posterior wall of the internal auditory canal. Portions of the labyrinth quite commonly are medial to the lateral end of the internal auditory canal. Although no single anatomic landmark is completely reliable for prevention of injury to the labyrinth, the singular nerve and its canal, and the operculum of the vestibular aqueduct, are used as important surgical landmarks. Careful measurements taken from preoperative CT scans can provide useful information during drilling of the posterior wall of the internal auditory canal.

The length of the internal auditory canal varies considerably, and knowing exactly how much posterior canal wall needs to be removed to adequately expose the tumor can help limit inadvertent injury to the labyrinth. Blind extraction of tumor from the internal auditory canal without removing the posterior wall poses a significant risk to the facial and/or auditory nerve integrity and increases the chance of leaving tumor at the fundus. Use of intraoperative angled endoscopes has been reported as an adjunct in performing this phase of the operation.

Every effort should be made to prevent bone dust from entering the subarachnoid space during the intradural drilling of the internal auditory canal. One probable cause for severe and intractable postoperative headache is spillage of bone dust into the subarachnoid space during tumor removal. Surgicel, Gelfoam, Telfa pads, and/or cottonoid strips are placed around the operative site so that bone dust adheres to them and is removed as they are removed. Once the internal auditory canal is exposed, the dura is opened and the tumor is removed. Although never proven, dissection from medial to lateral is thought to be less traumatic to both the cochlear nerve and to the vascular supply of the inner ear. The vestibular nerves are generally sacrificed, and unless hearing is to be preserved, the cochlear nerve is sacrificed as well.

Eventually, the surgeon is left with the anterior portions of the capsule adhered to the brain stem and cranial nerve VII. As the tumor capsule is carefully removed from the brain stem, the root entry zone of cranial nerve VII can be identified. The capsule is then carefully removed from the facial nerve with as little trauma as possible.

The facial nerve monitor facilitates this portion of the dissection. A meaningful amount of data now shows that results are improved when facial nerve monitoring is employed. A variety of techniques have been used to monitor the cochlear nerve when hearing preservation is desired. The most commonly used method is intraoperative ABR, but it has a number of disadvantages. Most importantly, it requires summing a large number of repetitions in order to extract a response from background noise. Consequently, a delay occurs between surgical manipulations and ABR changes. Direct cochlear nerve monitoring offers the advantage of real-time feedback, but a fully satisfactory method of placing and securing the electrode still is lacking.

Once tumor removal is complete and hemostasis is absolute, the dura is closed and the craniotomy defect is repaired, either by replacing the original bone flap or with methylmethacrylate or hydroxyapatite.

Middle cranial fossa approach

Although some surgeons use an extended middle cranial fossa approach for tumors that extend a centimeter or more outside the porus acusticus into the cerebellopontine angle, the middle cranial fossa approach is most frequently used for intracanalicular tumors. It is, by consensus, the approach of choice for small tumors that lie within the lateral portions of the internal auditory canal when hearing conservation is desired.

The head must be in the true lateral position. In young individuals with a supple neck, this can often be accomplished by turning the head to the side with the patient in the supine position. But if neck mobility is limited or concern exists that forced head turning will limit posterior fossa circulation or aggravate cervical spine disorders, then a true lateral (park-bench) position should be used.

Exposure must be centered over a vertically oriented line that passes approximately 1 cm anterior to the external auditory meatus. This is most easily accomplished through a linear incision. A posteriorly based U-shaped or curvilinear S-shaped incision can be used if concern exists about scar contracture. Depending upon the incision used, the temporalis muscle is incised or reflected inferiorly. A temporal craniotomy (approximately 5 cm by 5 cm) is performed with its base at the root of the zygoma. The dura is elevated from the floor of the middle cranial fossa, and osmotic diuretics, head elevation, hyperventilation, and steroids are used to limit cerebral edema.

The dura of the temporal lobe is then elevated off the superior surface of the temporal bone. The anterior extent of such elevation is usually the foramen spinosum, but the middle meningeal artery can be divided between clips and elevation continued anteriorly to the foramen ovale if additional exposure is desired. Dural elevation should proceed from posterior to anterior to avoid injury to an exposed greater superficial petrosal nerve or geniculate ganglion. Bleeding from the veins associated with the middle meningeal artery is often quite brisk but can generally be controlled with oxidized cellulose packing. Medial dissection continues to the free edge of the temporal bone.

The superior petrosal sinus is attached to the posterior surface of the temporal bone but not always at its superior edge. Care must be taken to avoid injuring it. If inadvertent injury occurs, bleeding can generally be controlled with intraluminal oxidized cellulose packing, electrocautery, or hemoclips. When extended middle cranial fossa approaches are employed, the superior petrosal sinus is deliberately divided between clips.

When it can be identified easily, the arcuate eminence is an extremely helpful landmark. Careful drilling can often identify the blue line of the superior canal inferior to it. Because the most difficult exposure to achieve during middle fossa surgery is the lateral posterior end of the internal auditory canal, dissection is performed as close to the superior semicircular canal as possible. The greater superficial petrosal nerve is generally easy to visualize and can be followed retrograde to the geniculate ganglion. It lies approximately 1.0 cm directly medial to the foramen spinosum. Once the area of the geniculate is identified, small diamond burrs are used to completely expose it. If the greater superficial petrosal nerve cannot be located and no other landmarks are available, the middle ear space can be entered from above and the head of the malleus can be identified. The geniculate ganglion lies approximately 2-3 mm anterior and medial to the head of the malleus.

Once the geniculate ganglion has been completely exposed, the labyrinthine portion of the nerve can be identified and followed medially and inferiorly into the internal auditory canal. The labyrinthine portion of the nerve takes a markedly vertical and medial course as it moves from the lateral geniculate ganglion to the proximal fundus of the internal auditory canal, which lies 5 or more millimeters deep to the geniculate ganglion. Some surgeons prefer to identify the internal auditory canal medially. Once the medial end of the canal is completely identified, they follow the canal laterally to the fundus of the internal auditory canal.

The bone overlying the internal auditory canal should be removed until approximately 270 º of the internal auditory canal is exposed. The most difficult area to expose is the point at which the superior vestibular nerve penetrates the labyrinthine bone to innervate the ampulla; however, exposure in this area is critical if the anatomy of the lateral end of the internal auditory canal is to be well visualized. If the superior vestibular nerve channel is identified, tumor removal is generally successful and relatively straightforward.

Larger tumors frequently have the facial nerve splayed out over the anterior superior portions of the tumor. Tumor removal begins, as with other approaches, by careful debulking. Once the tumor is debulked, enough room is created within the internal auditory canal to carefully remove the tumor capsule from the inferior surface of the facial nerve. Again, care must be taken to avoid torsion or twisting of the nerve during tumor removal.

Once the tumor has been completely removed, the integrity of the facial nerve is tested using the intraoperative facial nerve monitor. Presumably, the monitor has been in use throughout the case. If the facial nerve can be stimulated with low stimulus intensities, chances of good postoperative facial nerve function increase. Fat is then packed into the internal auditory canal after using bone wax to fill obvious air cells to prevent postoperative cerebrospinal fluid leak. The facial nerve monitor generally alerts the physician if fat is being packed in too tightly that the integrity of the facial nerve is being compromised. Retractors are removed, and the temporal lobe dura is allowed to relax. The bone plate is replaced using miniplates, and the wound is closed in multiple layers.

Previous
Next

Postoperative Details

Unless a complication develops, postoperative care is straightforward. The patient is generally kept in the ICU overnight so that rapid intervention is available if postoperative intracranial pressure increases or bleeding occurs. Vestibular rehabilitation should begin on the first postoperative day and continues twice daily throughout the hospital stay. Most patients can be discharged on the third or fourth postoperative day.

Previous
Next

Follow-up

A follow-up MRI is obtained within 6-12 months after surgical excision to document the completeness of tumor removal and to serve as a baseline for further follow-up scans. Assuming complete tumor removal, follow-up MRI should be obtained at 5 years and at 10 years. If the findings on the 10-year scan are normal, further imaging should be performed only if clinical circumstances require it. Postoperative MRI scans must be performed with fat-suppressed techniques if fat was used to obliterate the surgical site.

Previous
Next

Complications

Arterial injury

Injury to the AICA (much less commonly to the PICA) fortunately occurs very rarely. Although the AICA may be loosely attached to the tumor capsule, separating it from the tumor is generally fairly easy. Sacrificing the AICA itself has variable consequences depending upon the details of individual patient anatomy. It can be catastrophic and lead to devastating neurologic injury or death.

The branches of AICA most vulnerable to injury are, of course, the labyrinthine artery and branches supplying the facial nerve. Some otherwise perplexing cases of postoperative facial nerve weakness may be related to interruption of facial nerve vascular supply due to coagulation of small branches of the AICA. Failure to conserve hearing may be due to the disruption of cochlear blood supply. Because the labyrinthine artery may be intimately associated with the tumor, sacrifice often cannot be avoided. Conservation of the internal labyrinthine artery becomes more difficult as tumor size increases, doubtlessly accounting in some measure for the reduced success in hearing conservation with larger tumors. Neurologic injury or cerebral edema secondary to venous injury usually occurs as a result of injury to the sigmoid sinus itself, the petrosal vein of Dandy, or to the vein of Labbé.

Occlusion of the sigmoid sinus has variable effects depending largely upon the patient's unique venous anatomy. If the contralateral venous outflow tract is patent and communication through the torcula herophili is adequate, complete occlusion may be asymptomatic. The size of the 2 sigmoid sinuses is usually asymmetrical, with a greater volume of blood flowing through the right-sided sinus. Depending on how much more blood flows through the dominant sinus, occlusion of the dominant sinus can result in catastrophic increases in intracranial pressure, venous infarction, and even death. Because a number of potential collaterals exist between the torcula herophili and the jugular bulb, occlusion of the sigmoid sinus close to the torcula herophili is much more likely to have significant adverse effects than its occlusion close to the jugular bulb.

The petrosal vein of Dandy is a single large outflow tract in some patients but consists of series of several large veins in others. Its occlusion can result in edema and infarction of either the temporal lobe or the brain stem. Although neurologic injury secondary to occlusion of the Dandy vein is not inevitable, severe injury can occur, and the petrosal vein should be carefully preserved.

Occlusion of the vein of Labbé results in severe edema of the temporal lobe and temporal infarct. The edema can be sufficiently severe to cause brain herniation and death. The vein of Labbé generally enters the superior petrosal or transverse sinus between the torcula herophili and the point at which the superior petrosal sinus joins the transverse sinus. Thus, it is generally not directly in the field during acoustic tumor surgery. Occasionally, however, injury to the superior petrosal sinus results in its obliteration, and in some instances, the vein of Labbé is also injured or obstructed. Its presence and importance should be kept in mind during acoustic tumor surgery.

Hemorrhage into the posterior fossa in the immediate postoperative period can produce brainstem compression and death quite rapidly. Death can occur within a few minutes. Rapid neurologic deterioration in the first 24 hours postoperatively should raise suspicion of posterior fossa hemorrhage and mandates rapid and decisive intervention. If time permits, a rapid unenhanced CT scan should be obtained to secure the diagnosis while the operating room is prepared for an immediate return to surgery. If neurologic deterioration is rapid, forgo CT scanning and take the patient directly back to the operating theatre. If deterioration is very rapid with loss of consciousness, decerebrate posturing, and signs of imminent death, open the wound at the bedside to permit a posterior fossa decompression prior to emergent transportation of the patient to the operating room for wound exploration, debridement, and extensive irrigation.

Cerebellar injuries

Injury to the cerebellum was common in the early decades of the century, but its incidence has dramatically diminished in recent decades. Cerebellar injuries still occur but are generally not troublesome. The rotating shaft of the surgeon's burr is often the culprit because surgeons usually look past the shaft to the head of the burr to concentrate on bone removal. The shaft is often outside the surgical field of view. Such small areas of injury rarely have noticeable sequelae. Bleeding can be controlled with oxidized cellulose, cautery, or gelatin sponges, and edema is limited. Direct injury to the cerebellar hemisphere from compression and retraction, intracerebral hemorrhage, infarction due to alteration of the arterial inflow, or venous engorgement with our without infarction can produce severe edema of the entire cerebellum. Brainstem compression and/or intracranial herniation can produce death. Obstruction of the fourth ventricle and cerebral aqueduct can produce significant hydrocephalus.

Management should consist of aggressive use of osmotic diuretics, hyperventilation, and steroids. If medical management is unsuccessful, resection of part of the involved cerebellar hemisphere may be required.

Facial paralysis

In some cases, postoperative facial paralysis is unavoidable. The tumor may simply be attached too intimately to the thin attenuated facial nerve. Sometimes the tumor has enveloped the facial nerve, and tumor removal cannot be accomplished without resection of a portion of the facial nerve.

Eye care is critical to successful management of postoperative facial paralysis. Make liberal use of artificial tears specifically adapted to deal with dry eye (eg, Bion Tears). At night, place ocular lubricants (eg, Lacri-Lube) in the eye. If aggressive use of artificial tears during the day (q15-30min) and ointment at night is insufficient to maintain corneal hydration and exposure keratitis begins to develop, then consider use of an eye patch, placement of a gold weight, and lower lid shortening procedures. Tarsorrhaphy should be used only as a last resort and is only very rarely required. Coexisting injury to cranial nerve V with corneal hypesthesia or anesthesia vastly increases the problem in management. The lack of corneal sensation provides the patient no reliable guide as to the severity of corneal epithelial disruption. In such cases, tarsorrhaphy is much more likely to be required.

Cerebrospinal fluid complications

Transient abnormality of cerebrospinal fluid resorption may lead to mild temporary postoperative hydrocephalus. Although postoperative shunting can facilitate controlling cerebrospinal fluid fistula, it is now rarely, if ever required. Even when hydrocephalus is present in the preoperative period, it generally resolves without difficulty in the first few postoperative weeks.

Postoperative meningitis occurs in 2 forms. Bacterial meningitis is potentially life threatening and occurs in less than 1% of patients in the postoperative period. It can occur within the first 24-36 hours postoperatively, or its appearance may be delayed for a couple of weeks. Once initiated, it can progress very rapidly, and individuals can lapse from a normal level of consciousness into a dense coma in a matter of a few hours.

Consequently, intervention must be rapid. Diagnosis depends upon the presence of fever and, in the alert patient, the presence of headache, stiff neck, nuchal rigidity, and decreasing level of consciousness. If meningitis is suspected, perform an immediate lumbar puncture to obtain fluid for culture, but only after a CT scan has excluded the possibility of significant hydrocephalus, which could lead to brain herniation.

Obtain spinal fluid for Gram stain, glucose, protein, and white blood cell count. If the Gram stain is positive, spinal fluid glucose is less than 40 m/dL, or the spinal fluid white blood cell count is higher than 2500 cells/mm3, begin antibiotics immediately pending culture results. If the spinal fluid does not meet any of these criteria, closely observe the patient with the understanding that any deterioration of the condition requires a repeat lumbar puncture for additional spinal fluid.

Aseptic meningitis has been reported in 7-70% of postoperative neurosurgical patients. It shares with bacterial meningitis the clinical signs of increasing headache, fever, nuchal rigidity, and elevation of cerebrospinal fluid pressure. Spinal fluid profile in such patients shows marked elevation of white blood cell count and cerebrospinal fluid protein levels, but cerebrospinal fluid glucose remains within the reference range, and culture results (when they are finally complete) are normal. Corticosteroids are extremely helpful in managing aseptic meningitis, and their prompt administration often results in marked decrease in headache and nuchal rigidity within a few hours.

Spinal fluid leak through either the wound or the eustachian tube and middle ear occurs in 2-20% of patients. It can occur after translabyrinthine or retrosigmoid approaches and is less common after middle fossa craniotomy. When it follows retrosigmoid approaches, the path of egress is generally through pneumatized air cell tracts.

Cerebrospinal fluid is produced within the ventricular system at a rate of 0.3 mL/min or at about 500 mL/day. It enters the subarachnoid space in the posterior fossa via the midline and lateral foramen of the fourth ventricle. Contamination of the cerebrospinal fluid circulation by blood, bone dust, and necrotic debris at the time of surgery often impairs cerebrospinal fluid absorption directly by mechanical interference in the arachnoid villi or indirectly by inciting an inflammatory response within the subarachnoid space. The syndrome may vary from brief asymptomatic elevation of cerebrospinal fluid pressure to clinically manifested aseptic meningitis (discussed above). Cerebrospinal fluid escaping through the wound can initially be managed by resuturing the wound. Sometimes this results in elimination of the difficulty, while at other times it merely produces cerebrospinal fluid rhinorrhea, as the spinal fluid finds an alternate means of egress.

If the cerebrospinal fluid leak persists for more than 12-24 hours after initiation of conservative management, including pressure dressing and consistent head elevation, then consider reducing the cerebral spinal fluid pressure by 1 of 3 measures, including (1) multiple lumbar punctures, (2) continuous or intermittent drainage via lumbar intradural catheter, or (3) permanent cerebrospinal fluid diversion by means of an indwelling shunt.

When cerebrospinal fluid diversion is selected, the most common method is an indwelling subarachnoid catheter placed into the lumbar subarachnoid space. The drain is opened episodically so as to remove 200-400 mL of spinal fluid in any given 24-hour period. Some surgeons observe a minimum drainage period of 2 days, others 5 days. General consensus is that, if the drain has been in place for more than 5 days, it should be replaced to avoid infection. Variation among surgeons is considerable as to when reexploration is required. Some centers reexplore after 24-48 hours of drainage; other centers use as many as two 5-day trials of continuous lumbar drainage before considering a second operation.

Severe postoperative headache has long been associated with retrosigmoid procedures. This problem appears to have diminished considerably since the introduction of 2 intraoperative steps: (1) great care is taken to avoid contaminating the spinal fluid and subarachnoid space with bone dust, and (2) the bone flap is replaced and any residual bony defect is eliminated with methylmethacrylate or hydroxyapatite. The latter step eliminates the direct attachment of posterior cervical musculature to the dura. When postoperative headaches do occur, they should be managed with relatively high-dose nonsteroidal anti-inflammatory agents and aggressive regimens of manipulative physical therapy.

Previous
Next

Outcome and Prognosis

Tinnitus

Tinnitus becomes worse in only 6-20% of individuals after tumor removal. In a substantial number of individuals, the tinnitus remains unchanged. In about 25-60% of patients, tinnitus is eliminated or improved. Although 30-50% of patients who had no preoperative tinnitus develop it in the immediate postoperative period, such tinnitus only rarely becomes troublesome.

A study by Bell et al of 53 patients indicated that in patients who undergo acoustic neuroma resection, the prognosis for tinnitus resolution is worse for those who are younger, whose preoperative hearing was serviceable, and who have residual tumor postoperatively.[8]

On the other hand, a study by Alvarez et al found that younger patients had particularly good results on the Tinnitus Handicap Inventory questionnaire following translabyrinthine removal of vestibular schwannomas. The study also found that patients with the worst preoperative hearing demonstrated the best postoperative outcomes on the questionnaire.[9]

Recurrence/residual tumor

Recurrence is uncommon after acoustic tumor removal. Overall, the recurrence rate is less than 5%. The vast majority of recurrences follow retrosigmoid removal. Presumably, a small amount of tumor is left in the lateral end of the internal auditory canal where intraoperative visualization is difficult. Tumor recurrence may be suspected by recurring headache, altered sensation to the face, or dysarthria and dysphasia if the lower cranial nerves become involved.

Inflammation in the tumor bed may persist for months and even years after acoustic tumor removal, and consequently, areas of contrast enhancement are present on postoperative gadolinium MRI. Distinguishing tumor recurrence from postoperative inflammation can be quite difficult. Tumor recurrences tend to be globular while postoperative inflammatory enhancement tends to be linear. Often, however, one must view serial scans to detect tumor recurrence. Fat suppression techniques are essential for postoperative surveillance to distinguish recurrence from fat packing. Surveillance for postoperative tumor recurrence should persist for 8-10 years postoperatively.

Facial function

Preservation of facial function continues to improve, especially with the widespread use of facial nerve monitoring. However, facial nerve outcomes continue to vary according to tumor size. When tumors are smaller than 1.5 cm, good facial nerve function can be expected (House-Brackmann grade I-II) in more than 90% of patients.

In addition to tumor size, preoperative electrophysiologic testing can help predict postoperative outcome, although this testing is not commonly used. Demonstrable electrophysiologic abnormalities on nerve conduction studies, electromyography, and blink reflex testing correlate well with postoperative facial nerve deficits. Arriaga has shown that patients with poor facial nerve function at the time of discharge (House-Brackmann V-VI) had a 25% chance of recovery of normal function (House-Brackmann I-II). Less optimistic is the report of Sterkers. In his series of patients, anyone who had House-Brackmann III function or worse at a 4- to 6-week postoperative evaluation was left with significant deficit and generally had some synkinesis.

Facial nerve paralysis may be delayed and may develop within a few hours to a week or more after acoustic neuroma removal. Incidence of delayed facial palsy varies from 10-30%. The mechanism of action is unclear. Ischemia secondary to vasospasm, vascular injury, traction, nerve edema, stretching, and even a viral reactivation have been proposed. Unlike final facial nerve outcome, incidence of delayed facial paralysis does not appear to be related to tumor size.

The vast majority of individuals who have delayed onset of facial paralysis make complete and total recoveries. If deterioration is severe (more than 3 House-Brackmann grades), some chance of poor long-term outcome exists. Perioperative steroids are widely used in an attempt to enhance both immediate and long-term postoperative facial nerve function, but unequivocal evidence for their effectiveness is lacking. The use of perioperative antiviral agents is used by some centers to prevent delayed paralysis from viral reactivation, as in Bell palsy.

Hearing outcome

The ability to preserve hearing has increased substantially over the last decade or two. Depending on criteria for successful hearing conservation, hearing can be preserved in 30-80% of properly selected patients.

Stereotactic radiation (the gamma knife) does not appear to have a significantly higher rate of hearing conservation than does properly conducted surgery when long-term results are compared. Chopra, et al demonstrated a hearing preservation rate of 44% at 10-year follow-up in 216 patients receiving Gamma Knife radiosurgery.

Rosenberg et al and Tucci et al have both shown reasonable stability of hearing over time after surgery.[10] On the other hand, Shelton's study appears to show significant hearing deterioration in 30-50% of patients who originally had successful hearing preservation.

Rehabilitation

The hearing deficit after the removal of an acoustic neuroma can have a significant impact on quality of life. Rehabilitation options include a contralateral routing of signals (CROS) hearing aid or more recently a bone anchored hearing aid (BAHA). The BAHA consists of a surgical implanted titanium abutment that osseointegrates into the calvaria. A speech processor is then snapped onto the abutment, allowing sound to transmit through the skull to the normal contralateral ear.

In patients with neurofibromatosis type 2, all patients develop bilateral acoustic neuromas and most will eventually lose hearing in both ears. The auditory brainstem implant (ABI) can be inserted during a translabyrinthine craniotomy and provide patients the benefit of auditory input to assist with communication.

If a patient experiences facial nerve weakness and not total paralysis after surgical removal, often eye care consisting of artificial tears and lubricant will be sufficient until facial nerve function returns. If the facial nerve is severed intraoperatively, the nerve can be approximated at the time of surgery. If the patient has facial nerve paralysis 1 year after surgery, the chance of further recovery is remote. At this time, a hypoglossal-facial nerve graft may be considered. This will often result in improved tone and possibly eye closure.

Previous
Next

Future and Controversies

The relative roles of stereotactic radiation and surgery will remain controversial until the long-term results of radiation treatment protocols are clearly defined.

Previous
 
Contributor Information and Disclosures
Author

Joe Walter Kutz, Jr, MD, FACS Assistant Professor, Associate Residency Director, Neurotology Fellowship Director, Department of Otolaryngology–Head and Neck Surgery, University of Texas Southwestern Medical School

Joe Walter Kutz, Jr, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, Texas Medical Association, Triological Society, American Neurotology Society, Otosclerosis Study Group

Disclosure: Nothing to disclose.

Coauthor(s)

Peter S Roland, MD Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director, Clinical Center for Auditory, Vestibular, and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Chief of Pediatric Otology, Children’s Medical Center of Dallas; President of Medical Staff, Parkland Memorial Hospital; Adjunct Professor of Communicative Disorders, School of Behavioral and Brain Sciences, Chief of Medical Service, Callier Center for Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Auditory Society, The Triological Society, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, American Neurotology Society, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Otological Society

Disclosure: Received honoraria from Alcon Labs for consulting; Received honoraria from Advanced Bionics for board membership; Received honoraria from Cochlear Corp for board membership; Received travel grants from Med El Corp for consulting.

Brandon Isaacson, MD, FACS Associate Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center

Brandon Isaacson, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, North American Skull Base Society, Texas Medical Association, Triological Society, American Neurotology Society

Disclosure: Received consulting fee from Medtronic Midas Rex Insitute for consulting; Received medical advisory board from Advanced Bionics for board membership; Received consulting fee from Stryker for speaking and teaching.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Gerard J Gianoli, MD Clinical Associate Professor, Departments of Otolaryngology-Head and Neck Surgery and Pediatrics, Tulane University School of Medicine; President, The Ear and Balance Institute; Board of Directors, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, Triological Society, American Neurotology Society, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Vesticon<br/>Received none from Vesticon, Inc. for board membership.

Chief Editor

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;SymbiaAllergySolutions<br/>Received income in an amount equal to or greater than $250 from: Symbia<br/>Received from Allergy Solutions, Inc for board membership; Received honoraria from RxRevu for chief medical editor; Received salary from Medvoy for founder and president; Received consulting fee from Corvectra for senior medical advisor; Received ownership interest from Cerescan for consulting; Received consulting fee from Essiahealth for advisor; Received consulting fee from Carespan for advisor; Received consulting fee from Covidien for consulting.

Acknowledgements

Douglas D Backous, MD Director of Listen for Life Center, Department of Otolaryngology-Head and Neck Surgery, Virginia Mason Medical Center

Douglas D Backous, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Association for Research in Otolaryngology, North American Skull Base Society, Society for Neuroscience, and Washington State Medical Association

Disclosure: Nothing to disclose.

References
  1. Lin D, Hegarty JL, Fischbein NJ, et al. The prevalence of "incidental" acoustic neuroma. Arch Otolaryngol Head Neck Surg. 2005 Mar. 131(3):241-4. [Medline].

  2. Lee SH, Choi SK, Lim YJ, et al. Otologic manifestations of acoustic neuroma. Acta Otolaryngol. 2015 Feb. 135(2):140-6. [Medline].

  3. Telian SA. Management of the small acoustic neuroma: a decision analysis. Am J Otol. 1994 May. 15(3):358-65. [Medline].

  4. Hansen MR, Clark JJ, Gantz BJ, et al. Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation. Laryngoscope. 2008 Jun. 118(6):1023-30. [Medline].

  5. Boari N, Bailo M, Gagliardi F, et al. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg. 2014 Dec. 121 Suppl:123-42. [Medline].

  6. Powell C, Micallef C, Gonsalves A, Wharram B, Ashley S, Brada M. Fractionated stereotactic radiotherapy in the treatment of vestibular schwannoma (acoustic neuroma): predicting the risk of hydrocephalus. Int J Radiat Oncol Biol Phys. 2011 Jul 15. 80(4):1143-50. [Medline].

  7. Kim YH, Kim DG, Ho Han J, Chung HT, Kim IK, Song SW, et al. Hearing Outcomes After Stereotactic Radiosurgery for Unilateral Intracanalicular Vestibular Schwannomas: Implication of Transient Volume Expansion. Int J Radiat Oncol Biol Phys. 2012 May 12. [Medline].

  8. Bell JR, Anderson-Kim SJ, Low C, Leonetti JP. The Persistence of Tinnitus after Acoustic Neuroma Surgery. Otolaryngol Head Neck Surg. 2016 Apr 19. [Medline].

  9. Alvarez L, Ugarte A, Goiburu M, Urreta Barallobre I, Altuna X. Change in tinnitus after acoustic neuroma removal using a translabyrinthine approach. A Prospective study. Acta Otorrinolaringol Esp. 2016 Apr 8. [Medline].

  10. Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope. 2000 Apr. 110(4):497-508. [Medline].

  11. Brackmann DE, Fisher LM, Hansen M, et al. The effect of famciclovir on delayed facial paralysis after acoustic tumor resection. Laryngoscope. 2008 Sep. 118(9):1617-20. [Medline].

  12. Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2007 Jul 1. 68(3):845-51. [Medline].

  13. Combs SE, Thilmann C, Debus J, et al. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys. 2006 Apr 1. 64(5):1341-7. [Medline].

  14. House JW, Kutz JW Jr. Bone-anchored hearing aids: incidence and management of postoperative complications. Otol Neurotol. 2007 Feb. 28(2):213-7. [Medline].

  15. Isaacson B, Kileny PR, El-Kashlan HK. Prediction of long-term facial nerve outcomes with intraoperative nerve monitoring. Otol Neurotol. 2005 Mar. 26(2):270-3. [Medline].

  16. Isaacson B, Telian SA, El-Kashlan HK. Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches. Otolaryngol Head Neck Surg. 2005 Dec. 133(6):906-10. [Medline].

  17. Tos M, Stangerup SE, Caye-Thomasen P, et al. What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg. 2004 Feb. 130(2):216-20. [Medline].

 
Previous
Next
 
This table shows the distribution of presenting symptoms, ie, the symptom that brought the patient to a physician and that constituted the patient's chief ailment.
A small acoustic neuroma within the internal auditory canal is easily observed on postgadolinium MRI.
These large bilateral acoustic neuromas are easily observed on MRI. This patient has neurofibromatosis II. Both tumors were eventually removed, leading to anacusis. Facial nerve function remained entirely normal bilaterally.
The nerves of the internal auditory canal as observed in a cadaveric dissection are shown. The posterior wall of the internal auditory canal has been removed. F indicates the facial nerve. S is the superior vestibular nerve. VIII indicates the statoacoustic nerve as it leaves the brain stem, and P indicates the posterior ampullary nerve. The hollow arrow points to the posterior lip of the boney porous acusticus, and the solid arrow indicates the position of the vestibule. C indicates the cochlear aqueduct.
The bone that must be removed for a middle cranial fossa approach is indicated in yellow. The tumor is in orange.
The bone that must be removed for a translabyrinthine approach is indicated in yellow. The tumor is in orange.
The bone that must be removed for a posterior fossa approach is indicated in yellow. The tumor is in orange.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.